Showing results (411-420 of 439) with videos related to
Sort By:
Pageof 44
BMC Health Services Research|May 24, 2022
Improved hypertension control at six months using an adapted WHO HEARTS-based implementation strategy at a large urban HIV clinic in UgandaMartin Muddu, Fred C Semitala, Isaac Kimera, et al.Paediatric Anaesthesia|November 4, 2022
Evaluating the Women's Empowerment and Leadership Initiative: Supporting mentorship, career satisfaction, and well-being among pediatric anesthesiologistsNina Deutsch, Samuel D Yanofsky, Scott D Markowitz, et al.Journal of Human Hypertension|March 5, 2022
Integrated multi-month dispensing of antihypertensive and antiretroviral therapy to sustain hypertension and HIV controlIsaac Derickk Kimera, Christabellah Namugenyi, Jeremy I Schwartz, et al.Clinical Pharmacology and Therapeutics|July 3, 1999
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansJ I Schwartz, C C Chan, S Mukhopadhyay, et al.The Milbank Quarterly|September 1, 2021
Population Health Innovations and Payment to Address Social Needs Among Patients and Communities With DiabetesKathryn E Gunter, Monica E Peek, Jacob P Tanumihardjo, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjectsRita A Halpin, Arturo G Porras, Leslie A Geer, et al.Molecular Genetics and Metabolism|January 16, 1999
Two novel low-density lipoprotein receptor gene mutations (E397X and 347delGCC) in St. Petersburg familial hypercholesterolemiaK Chakir, C Kh, M M Ju, et al.Vaccine|September 11, 2021
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)Heather L Platt, Jose F Cardona, Miwa Haranaka, et al.PLOS Global Public Health|September 25, 2024
Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban UgandaDrew B Cameron, Lillian C Morrell, Faith Kagoya, et al.Clinical Pharmacology and Therapeutics|February 17, 2001
The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarinJ I Schwartz, K J Bugianesi, D L Ebel, et al.Pageof 44